SCHEMBL24311906

SCHEMBL24311906

CC1(C)OB(c2cc(-c3cccc4ccccc34)ccc2-c2ccccc2)OC1(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LPL P06858 2/20 0.44
▸ LIPG Q9Y5X9 2/20 0.44
▸ MCL1 Q07820 1/20 0.40
▸ ACMSD Q8TDX5 1/20 0.40
▸ ENPP3 O14638 1/20 0.40
▸ ENPP1 P22413 1/20 0.40
▸ CHRNA1 P02708 1/20 0.40
▸ CHRNG P07510 1/20 0.40
▸ CHRNB1 P11230 1/20 0.40
▸ CHRNB2 P17787 1/20 0.40
▸ SLC6A2 P23975 1/20 0.40
▸ CHRNB4 P30926 1/20 0.40
▸ SLC6A4 P31645 1/20 0.40
▸ CHRNA3 P32297 1/20 0.40
▸ CHRNA4 P43681 1/20 0.40
▸ SLC6A3 Q01959 1/20 0.40
▸ CHRND Q07001 1/20 0.40
▸ CA12 O43570 3/20 0.39
▸ CA1 P00915 3/20 0.39
▸ CA2 P00918 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26592328 0.96 LIPG (0.47) LPLLIPGMCL1ACMSDENPP3
SCHEMBL26279975 0.95 LIPG (0.50) LPLLIPGMCL1ACMSDENPP3
SCHEMBL24770616 0.88 ENPP1 (0.44) LPLLIPGENPP3ENPP1CHRNA1
SCHEMBL29458376 0.87 LIPG (0.44) LPLLIPGKDM4EALDH1A1MAPT
SCHEMBL24311871 0.87 LIPG (0.44) LPLLIPGKDM4EALDH1A1MAPT
SCHEMBL21051646 0.86 CHRNA1 (0.41) LPLLIPGMCL1ACMSDENPP3
SCHEMBL27254803 0.85 LIPG (0.52) LPLLIPGMCL1ACMSDENPP3
SCHEMBL29450684 0.83 LIPG (0.59) LPLLIPGMAPTATMSMN1; SMN2
SCHEMBL21125599 0.83 LIPG (0.59) LPLLIPGMAPTATMSMN1; SMN2
SCHEMBL27254827 0.83 LIPG (0.50) LPLLIPGMCL1ACMSDENPP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337532-A1 TRIAZINE COMPOUND, MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, ELECTRON TRANSPORT MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, AND ORGANIC LIGHT EMITTING DIODE TOSOH CORPORATION (JP) 2023-10-19 — — US disclosed
US-20230337532-A1 TRIAZINE COMPOUND, MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, ELECTRON TRANSPORT MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, AND ORGANIC LIGHT EMITTING DIODE TOSOH CORPORATION (JP) 2023-10-19 — — US disclosed
WO-2022075219-A1 TRIAZINE COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ELECTRON TRANSPORT MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, AND ORGANIC ELECTROLUMINESCENT ELEMENT 東ソー株式会社 2022-04-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337532-A1 TRIAZINE COMPOUND, MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, ELECTRON TRANSPORT MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, AND ORGANIC LIGHT EMITTING DIODE ARNT, TPH1, AHR LPL 1687/4885LIPG 4258/4885MCL1 3998/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback